West Pharmaceutical Servs Raises FY2026 GAAP EPS Guidance from $7.79-$8.14 to $8.15-$8.50 vs $7.91 Est

Benzinga Newsdesk www.benzinga.com Positive 93.2%

Neg 0% Neu 0% Pos 93.2%

West Pharmaceutical Servs (NYSE:WST) raises FY2026 GAAP EPS guidance from $7.79-$8.14 to $8.15-$8.50 vs $7.91 analyst estimate..